Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita

REFERENCES

• Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110(4):768–779.
   PubMed Web of Science ®Google Scholar
• Marrone A, Walne A, Dokal I. Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr Opin Genet Dev. 2005;15(3):249–257.
   PubMed Web of Science ®Google Scholar
• Vulliamy TJ, Dokal I. Dyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex. Biochimie. 2008;90(1):122–130.
   PubMed Web of Science ®Google Scholar
• Sirinavin C, Trowbridge AA. Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature. J Med Genet. 1975;12(4):339–354.
   PubMed Web of Science ®Google Scholar
• Davidson HR, Connor JM. Dyskeratosis congenita. J Med Genet. 1988;25(12):843–846.
   PubMed Web of Science ®Google Scholar
• Teixeira LF, Shields CL, Marr B, Horgan N, Shields JA. Bilateral retinal vasculopathy in a patient with dyskeratosis congenita. Arch Ophthalmol. 2008;126(1):134–135.
   PubMedGoogle Scholar
• Nazir S, Sayani N, Phillips PH. Retinal hemorrhages in a patient with dyskeratosis congenita. J AAPOS. 2008;12(4):415–417.
   PubMed Web of Science ®Google Scholar
• Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107(7):2680–2685.
   PubMed Web of Science ®Google Scholar
• Bessler M, Du HY, Gu B, Mason PJ. Dysfunctional telomeres and dyskeratosis congenita. Haematologica. 2007;92(8):1009–1012.
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413(6854):432–435.
   PubMed Web of Science ®Google Scholar
• Feng J, Funk WD, Wang S, Weinrich SL, Avilion AA, Chiu C, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science. 1995;1;269(5228):1236–1241.
   Web of Science ®Google Scholar
• Jády BE, Richard P, Bertrand E, Kiss T. Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell. 2006;17(2):944–954.
   PubMed Web of Science ®Google Scholar
• Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989;337(6205):331–337.
   PubMed Web of Science ®Google Scholar
• Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 1990;344(6262):126–132.
   PubMed Web of Science ®Google Scholar
• Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA. 2005;102(44):15960–15964.
   PubMed Web of Science ®Google Scholar
• Goldman F, Bouarich R, Kulkarni S, Freeman S, Du HY, Harrington L, Mason PJ, Londoño-Vallejo A, Bessler M. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci USA. 2005;102(47):17119–17124.
   PubMed Web of Science ®Google Scholar
• Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;15;277(5328):955–959.
   Web of Science ®Google Scholar
• Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19(1):32–38.
   PubMed Web of Science ®Google Scholar
• Hassock S, Vetrie D, Giannelli F. Mapping and characterization of the X-linked dyskeratosis congenita (DKC) gene. Genomics. 1999;1;55(1):21–27.
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36(5):447–449.
   PubMed Web of Science ®Google Scholar
• Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91(1):25–34.
   PubMed Web of Science ®Google Scholar
• De Boeck K, Degreef H, Verwilghen R, Corbeel L, Casteels-Van Daele M. Thrombocytopenia: first symptom in a patient with dyskeratosis congenita. Pediatrics. 1981;67(6):898–903.
   PubMed Web of Science ®Google Scholar